247 related articles for article (PubMed ID: 33420369)
1. Comprehensive characterisation of intronic mis-splicing mutations in human cancers.
Jung H; Lee KS; Choi JK
Oncogene; 2021 Feb; 40(7):1347-1361. PubMed ID: 33420369
[TBL] [Abstract][Full Text] [Related]
2. Computational analysis of splicing errors and mutations in human transcripts.
Kurmangaliyev YZ; Gelfand MS
BMC Genomics; 2008 Jan; 9():13. PubMed ID: 18194514
[TBL] [Abstract][Full Text] [Related]
3. The deep intronic c.903+469T>C mutation in the MTRR gene creates an SF2/ASF binding exonic splicing enhancer, which leads to pseudoexon activation and causes the cblE type of homocystinuria.
Homolova K; Zavadakova P; Doktor TK; Schroeder LD; Kozich V; Andresen BS
Hum Mutat; 2010 Apr; 31(4):437-44. PubMed ID: 20120036
[TBL] [Abstract][Full Text] [Related]
4. Ab initio prediction of mutation-induced cryptic splice-site activation and exon skipping.
Divina P; Kvitkovicova A; Buratti E; Vorechovsky I
Eur J Hum Genet; 2009 Jun; 17(6):759-65. PubMed ID: 19142208
[TBL] [Abstract][Full Text] [Related]
5. Splicing mutations in inherited retinal diseases.
Weisschuh N; Buena-Atienza E; Wissinger B
Prog Retin Eye Res; 2021 Jan; 80():100874. PubMed ID: 32553897
[TBL] [Abstract][Full Text] [Related]
6. Pseudoexon activation in disease by non-splice site deep intronic sequence variation - wild type pseudoexons constitute high-risk sites in the human genome.
Petersen USS; Doktor TK; Andresen BS
Hum Mutat; 2022 Feb; 43(2):103-127. PubMed ID: 34837434
[TBL] [Abstract][Full Text] [Related]
7. Clinical Characteristics of
Weisschuh N; Mazzola P; Bertrand M; Haack TB; Wissinger B; Kohl S; Stingl K
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065499
[TBL] [Abstract][Full Text] [Related]
8. Deep-intronic ABCA4 variants explain missing heritability in Stargardt disease and allow correction of splice defects by antisense oligonucleotides.
Sangermano R; Garanto A; Khan M; Runhart EH; Bauwens M; Bax NM; van den Born LI; Khan MI; Cornelis SS; Verheij JBGM; Pott JR; Thiadens AAHJ; Klaver CCW; Puech B; Meunier I; Naessens S; Arno G; Fakin A; Carss KJ; Raymond FL; Webster AR; Dhaenens CM; Stöhr H; Grassmann F; Weber BHF; Hoyng CB; De Baere E; Albert S; Collin RWJ; Cremers FPM
Genet Med; 2019 Aug; 21(8):1751-1760. PubMed ID: 30643219
[TBL] [Abstract][Full Text] [Related]
9. Disease-causing mutations improving the branch site and polypyrimidine tract: pseudoexon activation of LINE-2 and antisense Alu lacking the poly(T)-tail.
Meili D; Kralovicova J; Zagalak J; Bonafé L; Fiori L; Blau N; Thöny B; Vorechovsky I
Hum Mutat; 2009 May; 30(5):823-31. PubMed ID: 19280650
[TBL] [Abstract][Full Text] [Related]
10. Rules and tools to predict the splicing effects of exonic and intronic mutations.
Ohno K; Takeda JI; Masuda A
Wiley Interdiscip Rev RNA; 2018 Jan; 9(1):. PubMed ID: 28949076
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Pathogenic Pseudoexons Reveals Novel Mechanisms Driving Cryptic Splicing.
Keegan NP; Wilton SD; Fletcher S
Front Genet; 2021; 12():806946. PubMed ID: 35140743
[TBL] [Abstract][Full Text] [Related]
12. BAP1 missense mutation c.2054 A>T (p.E685V) completely disrupts normal splicing through creation of a novel 5' splice site in a human mesothelioma cell line.
Morrison A; Chekaluk Y; Bacares R; Ladanyi M; Zhang L
PLoS One; 2015; 10(4):e0119224. PubMed ID: 25830670
[TBL] [Abstract][Full Text] [Related]
13. Effects of intronic mutations in the LDLR gene on pre-mRNA splicing: Comparison of wet-lab and bioinformatics analyses.
Holla ØL; Nakken S; Mattingsdal M; Ranheim T; Berge KE; Defesche JC; Leren TP
Mol Genet Metab; 2009 Apr; 96(4):245-52. PubMed ID: 19208450
[TBL] [Abstract][Full Text] [Related]
14. Computational prediction of splicing regulatory elements shared by Tetrapoda organisms.
Churbanov A; Vorechovský I; Hicks C
BMC Genomics; 2009 Nov; 10():508. PubMed ID: 19889216
[TBL] [Abstract][Full Text] [Related]
15. Short cryptic exons mediate recursive splicing in Drosophila.
Joseph B; Kondo S; Lai EC
Nat Struct Mol Biol; 2018 May; 25(5):365-371. PubMed ID: 29632374
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide detection of human intronic AG-gain variants located between splicing branchpoints and canonical splice acceptor sites.
Zhang P; Chaldebas M; Ogishi M; Al Qureshah F; Ponsin K; Feng Y; Rinchai D; Milisavljevic B; Han JE; Moncada-Vélez M; Keles S; Schröder B; Stenson PD; Cooper DN; Cobat A; Boisson B; Zhang Q; Boisson-Dupuis S; Abel L; Casanova JL
Proc Natl Acad Sci U S A; 2023 Nov; 120(46):e2314225120. PubMed ID: 37931111
[TBL] [Abstract][Full Text] [Related]
17. Intronic PAH gene mutations cause a splicing defect by a novel mechanism involving U1snRNP binding downstream of the 5' splice site.
Martínez-Pizarro A; Dembic M; Pérez B; Andresen BS; Desviat LR
PLoS Genet; 2018 Apr; 14(4):e1007360. PubMed ID: 29684050
[TBL] [Abstract][Full Text] [Related]
18. All reported non-canonical splice site variants in GLA cause aberrant splicing.
Okada E; Horinouchi T; Yamamura T; Aoto Y; Suzuki R; Ichikawa Y; Tanaka Y; Masuda C; Kitakado H; Kondo A; Sakakibara N; Ishiko S; Nagano C; Ishimori S; Usui J; Yamagata K; Matsuo M; Nozu K
Clin Exp Nephrol; 2023 Sep; 27(9):737-746. PubMed ID: 37254000
[TBL] [Abstract][Full Text] [Related]
19. Predicting Splicing from Primary Sequence with Deep Learning.
Jaganathan K; Kyriazopoulou Panagiotopoulou S; McRae JF; Darbandi SF; Knowles D; Li YI; Kosmicki JA; Arbelaez J; Cui W; Schwartz GB; Chow ED; Kanterakis E; Gao H; Kia A; Batzoglou S; Sanders SJ; Farh KK
Cell; 2019 Jan; 176(3):535-548.e24. PubMed ID: 30661751
[TBL] [Abstract][Full Text] [Related]
20. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.
Wimmer K; Roca X; Beiglböck H; Callens T; Etzler J; Rao AR; Krainer AR; Fonatsch C; Messiaen L
Hum Mutat; 2007 Jun; 28(6):599-612. PubMed ID: 17311297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
